ArticleFoods (Basel, Switzerland)2026
Encapsulation of Citral by Sodium Carboxymethyl Starch and Sodium Caseinate: Antibacterial Activity Characterization and Evaluation.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Citral exhibits favorable broad-spectrum antibacterial activity; however, it is prone to oxidative degradation or structural changes. To improve its stability and practical applicability, citral-loaded microcapsules were prepared using sodium carboxymethyl starch (CMS) and sodium caseinate (CS) via emulsification and freeze-drying. We then investigated the effects of the CMS-to-CS mass ratio on the physicochemical properties and microstructure of the microcapsules, and systematically evaluated the antibacterial activity and underlying mechanisms of the citral-loaded microcapsules against typical foodborne pathogenic bacteria and food-related bacteria. The results showed that when the CMS-to-CS mass ratio was 3:1, the microcapsules prepared exhibited the highest encapsulation efficiency (83.87%). The molecular interactions between citral and the wall materials were confirmed. The citral-loaded microcapsules demonstrated good thermal stability and a compact morphology with dense blocks. Furthermore, treatment with the citral-loaded microcapsules led to the leakage of intracellular contents and compromised the cell membrane integrity of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.